Top 15 Swiss Biotech Startups Making a Difference in Europe
Switzerland has long been known as a booming biotech hotspot in Europe that boasts many…
09/06/2021 - 11 minutes
Switzerland
Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease
Swiss biotech Chord Therapeutics launched this week with a €13.7M Series A, becoming the latest…
15/10/2020 - 3 minutes
BioMarin Partners Swiss Biotech to Develop Cardiac Gene Therapies
US biotech BioMarin has partnered Swiss startup DiNAQOR to develop gene therapies to treat rare,…
07/05/2020 - 2 minutes
Scientists Connect Brain Cells to Machines Over the Internet
An international group of researchers has set up a brain-machine interface between cultured nerve cells…
27/02/2020 - 3 minutes
Novadiscovery Carries out Clinical Trials using AI and Simulations
Novadiscovery, based in Lyon, France, is developing AI-based simulation technology to predict clinical trial outcomes…
14/02/2020 - 3 minutes
Swiss Biotech Raises €16M to Treat Autism Spectrum Disorder
Stalicla has bagged €16.3M in a Series A round to test drugs repurposed using AI…
04/02/2020 - 2 minutes
A Future Gene Therapy Could Be Delivered in Tiny ‘Nanocontainers’
A Swiss research group has developed tiny plastic particles that could carry gene therapies to…
28/01/2020 - 3 minutes
€14M Series A to Fund Cancer Immunotherapy Boosting Checkpoint Inhibitors
The Swiss biotech ImmunOs Therapeutics has raised a Series A round of €13.7M (CHF 15M)…
11/12/2019 - 2 minutes
ObsEva’s Oral Treatment for Uterine Fibroids Nails Phase III
An oral drug developed by the Swiss company ObsEva was shown to reduce menstrual bleeding…
10/12/2019 - 2 minutes
Scientists Use DNA Data Storage to Hide Information in Everyday Objects
Scientists have developed a method for storing DNA data in 3D-printed objects, which could one…
09/12/2019 - 4 minutes
Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III
A small molecule drug developed by the US company ChemoCentryx and its Swiss partner Vifor…
26/11/2019 - 3 minutes
€15M to Take Swiss Biotech’s Liver Cirrhosis Treatment to Phase II
Versantis has raised a Series B of €14.6M (CHF 16M) to advance its treatment for…
18/09/2019 - 3 minutes
